Transfer of Risperidone and 9-Hydroxyrisperidone into Human Milk
Authors:
- 1 February 2004
- journal article
- case report
- Published by SAGE Publications in Annals of Pharmacotherapy
- Vol. 38 (2) , 273-276
Abstract
OBJECTIVE: To quantify the transfer of risperidone and its active metabolite 9-hydroxyrisperidone into breast milk, estimate the amount the infant receives, measure infant plasma concentrations, and clinically assess the safety of breast feeding during maternal risperidone administration. CASE SUMMARIES: The transfer of risperidone and 9-hydroxyrisperidone into milk was studied in 2 breast-feeding women and one woman with risperidone-induced galactorrhea. Plasma samples were available from 2 of the women and from both breast-fed infants. The milk/plasma concentration ratio determined in 2 women was <0.5 for both compounds. The calculated relative infant “doses” were 2.3%, 2.8%, and 4.7% (as risperidone equivalents) of the maternal weight-adjusted doses. Risperidone and 9-hydroxyrisperidone were not detected in the plasma of the 2 breast-fed infants studied, and no adverse effects were noted. DISCUSSION: Risperidone therapy is sometimes necessary in breast-feeding women, raising the issue of safety in the exposed infants. Our study shows that the relative infant dose is lower than the arbitrary 10% level of concern. The data provide clear guidance on infant exposure for the cases presented. CONCLUSIONS: Maternal risperidone therapy is unlikely to be a significant hazard for the breast-fed infant in the short term. Nevertheless, decisions on whether a woman may breast-feed should be made as an individual risk-benefit analysis.Keywords
This publication has 5 references indexed in Scilit:
- Effects of Various CYP2D6 Genotypes on the Steady-State Plasma Concentrations of Risperidone and Its Active Metabolite, 9-Hydroxyrisperidone, in Japanese Patients With SchizophreniaTherapeutic Drug Monitoring, 2003
- Studying Drugs in Human Milk: Time to Unify the ApproachJournal of Human Lactation, 2002
- No Complications With Risperidone Treatment Before and Throughout Pregnancy and During the Nursing PeriodThe Journal of Clinical Psychiatry, 2002
- Risperidone Distribution and Excretion Into Human Milk: Case Report and Estimated Infant Exposure During Breast-FeedingJournal of Clinical Psychopharmacology, 2000
- Monographs on individual drugs1996